| Literature DB >> 7232848 |
Abstract
Twenty-six new agents of natural products origin which are under preclinical development as potential antitumor agents at the National Cancer Institute are discussed with reference to their sources, structures, antitumor activity, current status, and future potential as clinically effective drugs.Mesh：
Substances：
Year: 1981 PMID： 7232848 DOI： 10.1007/978-3-642-81565-2_14
Source DB: PubMed Journal: Recent Results Cancer Res ISSN： 0080-0015